ATS 2024
Advertisement
Research presented at ATS 2024 showed how patients with multimorbidity and limited life expectancy perceive screening.
Research presented at ATS 2024 addressed questions surrounding the use of this regimen in older adults.
Further efforts to improve electronic health record documentation of smoking history are “essential” to mitigate ...
The study addressed the limited information on the trajectory of patient-centered outcomes in this setting.
The findings offer insight into tumorigenesis in cigarette smoke exposure conditions.
Research presented at ATS 2024 highlights the “potential harmful effects of alternative e-cigarette use.”
It was critical to offer the screening program because most veterans with lung cancer are diagnosed at stage III or IV.
A study presented at ATS 2024 shed light on the outcomes of patients with cannabis use disorder and lung cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.